Recent in vivo studies have shown low dopamine D 2 receptor and dopamine transporter densities among late onset (type 1) alcoholics. We have now studied 6-[ 18 F]-FDOPA (FDOPA) uptake in 10 type 1 alcoholics and eight matched controls to test the hypothesis that striatal presynaptic dopamine function is lower among alcoholics. Markedly low FDOPA uptake (K i ) was observed in the left caudate of two alcoholic patients, but the mean striatal uptake values of the patient group were higher than those of the control group. The greatest difference was observed in the mean FDOPA intake in the left putamen, which was 28% higher in the patient group (t = 3.00, P = 0.008, d.f. = 16, independent samples t-test), and in the right caudate (difference 36%, t = 2.87, P = 0.01). The elevated FDOPA uptake in putamen and caudate correlated with poor Wisconsin Card Sorting Test (WCST) performance (error %) among alcoholics (correlation coefficients from 0.49 to 0.56), which suggests that the magnitude of presynaptic dopamine function alteration correlates with the degree of disability to modify one's behavior. The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism, but on the contrary indicate an increased presynaptic dopamine function. This may represent a compensatory mechanism to low postsynaptic DA function. The low presynaptic DA function observed in the left caudate of two patients suggests that type 1 alcoholism may be a heterogeneous disorder.
Introduction
Data obtained from animal studies imply that the development of alcohol dependence is associated with the dopamine (DA) function in the striatum and the limbic system. [1] [2] [3] [4] [5] [6] [7] Many genetic studies of humans have suggested that the D 2 receptor gene allele A1 is associated with substance abuse, [8] [9] [10] [11] but several other studies have given controversial results. [12] [13] [14] [15] [16] [17] [18] Our previous in vivo study with positron emission tomography (PET) showed that striatal D 2 receptor density and affinity were reduced in late-onset, non-violent alcoholic subjects (reminiscent of Cloninger type 1 alcoholics) 19 when compared with healthy controls. 20 Recently we observed that the striatal dopamine re-uptake site densities are markedly lower among non-violent alcoholics than in healthy controls while habitually violent alcoholics (reminiscent of Cloninger type 2) 19 have slightly higher DA transporter densities than con- trols. 21 These findings on D 2 receptors and DA transporters have been regarded as the first identification of a specific neuroregulatory deficit in type 1 alcoholism. 22 Results of a recent PET study on alcoholics showed lower D 2 -receptor density, but DA transporter densities were not decreased among five alcoholic patients with a mean alcoholism onset age of 19 years (implying that many of these subjects were possibly type 2 rather than type 1 alcoholics). 23 The aim of this study was to measure the presynaptic dopamine function with PET and 6-[
18 F]-fluorodopa (FDOPA) uptake to test the hypothesis that overall dopaminergic turnover is lower in the striatum of type 1 19 alcoholics when compared with healthy controls.
Material and methods

Index subjects and controls
The procedure was approved by the local ethical committees (Kuopio University Hospital and Turku University/Turku University Central Hospital) and all subjects gave written informed consent. All 18 subjects were white caucasian Finnish citizens. FDOPA uptake was studied with PET in eight age-and sex-matched healthy control subjects with no neurological or psychiatric disorders nor any kind of medication (all males, aged 34-56 years, mean 44.2 years, all righthanded), and in 10 non-violent alcoholics (all males, aged 43-55 years, mean 47.7 years, all right-handed). The background data on controls and patients are shown in Table 1 . Three alcoholics were omitted from the original sample of 13 subjects because of non-compliance to study protocol. All subjects were recruited with the help of a local rehabilitation center for alcoholics, where they had obtained non-pharmacological treatment for alcoholism. The subjects were selected from the patient population by a psychiatric nurse who chose those subjects who had little or no psychiatric or somatic co-morbidity and were known not to be using antidepressants, neuroleptics, nor other psychotropic drugs. All patients had had difficulties in their jobs due to their alcoholism, but none of them had committed any criminal offence. All of them fulfilled the criteria for Cloninger type 1 alcoholism. 19 The onset of the dependence was defined as the first time of occurrence of significant difficulties in their job, social relationships or health condition. Their abstinence time prior to PET measurement ranged from 3 days to 42 months (mean ± s.d. 137.9 ± 400.7 days). All patients were interviewed by a psychologist and completed the structured interview questionnaires of the Michigan Alcoholism Screening Test (MAST), Severity of Alcohol Dependence Questionnaire (SADQ), Zung depression and anxiety scales, and Hopkins Symptom Checklist (90-SCL). All subjects were also studied using the Wechsler Adult Intelligence Scale -Revised (WAIS-R) and Wisconsin Card Sorting Test (WCST).
PET procedure 6-[
18 F]-FDOPA preparation and HPLC analysis of unchanged FDOPA and labeled metabolites in arterial plasma were performed as described. 24 The PET experiments were performed using a whole-body PET scanner (ECAT 931/08-12). 25 Radioactivity in the brain was measured for 60 min after giving 4-5 mCi 6-[
18 F]-L-FDOPA intravenously. Karbidopa 100 mg p.o. was given 1.5 h before the study. The head was fixed in a vacuum head holder which was further stabilized with glass fiber tape. The positioning of the head in the gantry was according to the cantho-meatal line. Laser beams in the gantry and ink marks on the head were used to control the position of the head. Region-ofinterest (ROI) definitions were based on MRI images without knowledge of diagnosis. Each patient/control underwent a T1 weighted MRI scan (Siemens) with 1.5-mm slice thickness (3D-MPRAGE sequence, TR 10 ms, TE 4 ms). PET-MRI image alignment was done by using a surface-fitting procedure 26 and subsequent MRI image reslicing to match the two middlemost PET planes transversing the striatum. Occipital cortical ROIs were also defined on these slices. K i values reflecting uptake and decarboxylation of [ 18 F]FDOPA by the dopaminergic nerve terminals were calculated by using a graphical analysis 27 with arterial plasma input and occipital cortex as a dopamine nerve terminal-free reference area.
Results
The fraction of unchanged 6-[
18 F]-FDOPA in arterial plasma was slightly lower in patients (Figure 1 ). Fractions of the 3-O-methyl metabolite were identical in controls and patients. Figure 2 demonstrates the 6[
18 F]-FDOPA and MRI-scans in an alcoholic subject in two consecutive slices. The ligand uptake is markedly low in the left caudate, but the MRI shows no structural abnormalities in the same region. The average FDOPA K i values in the putamen and caudate among controls and index subjects are shown in Table 2 , and the scatter plots of the K i values in the caudate and the putamen among different individuals in Figure 3 . The results show that the FDOPA K i values are 39-59% lower in the left caudate of two alcoholic patients when compared with the mean value of controls. The mean striatal FDOPA uptake values were 9-36% higher in the alcoholic group, but the differences between the groups were statistically significant (also with Bonferroni correction) only in the right caudate (t = 2.87, P = 0.01; d.f. = 16, independent samples t-test) and in the left putamen (t = 3.00, P = 0.008).
The associations between the clinical variables and the averaged (left + right) FDOPA K i values of the caudate and putamen among index subjects are shown in Table 3 . No marked associations (͉r͉Ͼ 0.50) were found 
Discussion
The FDOPA K i value is an index of presynaptic DA synthetic capacity and as such does not directly tell the intrasynaptic concentrations of dopamine. Recent 6-[ 18 F]-L-FDOPA PET studies on amphetamineinduced changes in primate striatum suggest, however, a good correspondence between directly measured DA levels and FDOPA K i values. 28 The mean FDOPA K i values in the left and the right caudate and in the left and the right putamen were higher among alcoholic patients when compared with matched healthy controls, but the differences were statistically significant only in the right caudate and the left putamen at group level. The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism, but on the contrary indicate an increased dopamine synthesis in the striatum. A markedly low striatal presynaptic dopamine activity was observed in the left caudate in two patients, which implies that type 1 alcoholism is probably a heterogeneous disorder concerning its molecular aetiology. The very low FDOPA activity observed in the left caudate of two patients is of interest as lesions of the left caudate have been observed to be associated with depressive symptoms. 29 However, our patients with low activity in this region clearly did not have more depressive symptoms than other index subjects (scores 31 and 45 points; mean ± s.d. 31.9 ± 7.3). The very low dopamine turnover in the left caudate of two patients may be secondary to long-lasting ethanol exposure, or it may reflect an inborn neurobiological variation which results in vulnerability to relatively severe, early-onset alcoholism. The results imply that the dopamine function is not significantly associated with striatal atrophy or with the recent ethanol intake (time of abstinence), or otherwise, the ethanol-induced effect is very long lasting and stable over time.
The learning of new rules and the ability to modify one's behavior can be studied with WCST. Clinical data accumulated during the last decades imply that patients with frontal lobe lesions have poor WCST performance. Our results showed an association between the K i values in both caudate and putamen and the WCST scores, although the finding did not reach statistical significance (P-values 0.09 and 0.15) due to the relatively small number of subjects. The observed moderately high negative correlation between the performance in the WCST and the striatal FDOPA uptake among alcoholics is in line with experimental animal studies which imply that impaired dopaminergic function is associated with deficits in cognitive processing, 30 and with the fact that prefrontal cortex and basal ganglia have intense functional interactions. The results in WCST were not explained by poor overall cognitive performance, since mean Wechsler Adult Intelligence Scale -Revised (WAIS-R) score of alcoholics was 111 points. The elevated FDOPA uptake (which correlated to poor WCST performance) may be a secondary mechanism to compensate for poor postsynaptic dopamine function in alcoholic subjects. If it is a trait-dependent variable, it may be associated with poor ability to modify one's behavior and with the development of addiction.
There may be several different primary pathophysiological mechanisms in alcohol dependence. In vivo PET and single photon emission tomography (SPECT) receptor and transporter studies are not able to provide explicit information on the overall function of the dopaminergic transmission. The low D 2 receptor den-sity and affinity measured with [ 11 C] raclopride binding can be explained by the decreased number of receptors per synapse or by decreased number of synapses such as in Parkinson's disease (PD) or, alternatively, by increased endogenous synaptic dopamine activity which competes in D 2 binding with the ligand. In the same way, the low DA transporter density can be explained by the decreased number of synapses as in PD or by the normal number of synapses with decreased number of transporters per synapse. One possibility is that some type 1 alcoholics have disturbed postsynaptic dopamine transmission eg at the level of D 2 receptor binding or due to dysfunction of G-protein second messenger systems. This could lead to a compensatory increase in the presynaptic dopamine synthesis and compensatory decrease in DA reuptake, which would both increase dopamine transmission, but despite this, possibly not achieving the normal level of transmission.
The observed great dispersion in striatal dopamine activity in the left caudate among our patients may be associated with the vulnerability to development of addiction, which suggests that drugs stabilizing dopamine transmission such as partial dopamine agonists might be relevant novel candidates for the pharmacological treatment of type 1 alcoholism. This class of drugs such as (+) -UH232 31 might be used to dampen the rapid transients in dopamine release during acute ethanol-induced euphoria. A partial agonist would not decrease dopamine transmission in the long run, but would prevent rapid changes in dopamine release which may be associated with the reinforcement and development of addiction.
Conclusions
The results do not give support to the hypothesis of generally decreased striatal dopamine turnover in type 1 alcoholism but, on the contrary, indicate an increased presynaptic dopamine synthesis. This may represent a compensatory mechanism to low postsynaptic DA function. The low presynaptic DA function observed in the left caudate of two patients suggests that type 1 alcoholism may be a heterogeneous disorder. The observed high correlation between the poor performance in the WCST and the elevated striatal FDOPA uptake is in line with experimental animal studies which imply that impaired dopaminergic function is associated with learning deficits. If the increased presynaptic DA synthesis is a trait-dependent variable, it may be associated with disability to modify one's behavior and with the development of addiction. The observed great dispersion in the striatal dopamine activity in the left caudate among our patients may be associated with the vulnerability to development of addiction, which suggests that drugs stabilizing dopamine transmission such as partial dopamine agonists might be relevant novel candidates for the pharmacological treatment of type 1 alcoholism.
